Protective effect of Reducdyn against the chromosome damaging activity of 2,3,5-triethyleneimine-benzoquinone-1,4 on human lymphocytes in vitro.
D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D002869:Chromosome Aberrations; D002875:Chromosomes / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006710:Homocysteine / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D007783:Lactones / Q000494:pharmacology; D008214:Lymphocytes / Q000187:drug effects* / Q000648:ultrastructure; D009153:Mutagens / Q000037:antagonists & inhibitors; D011837:Radiation-Protective Agents / Q000494:pharmacology*; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D013997:Time Factors; D014228:Triaziquone / Q000037:antagonists & inhibitors* / Q000494:pharmacology
D007783:Lactones; D009153:Mutagens; D011837:Radiation-Protective Agents; D013438:Sulfhydryl Compounds; D006710:Homocysteine; D014228:Triaziquone